| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520402A Unsymmetrical cyclic diamine compound |
| 08/11/2004 | CN1520400A Cyclic diamine compounds bearing six-membered cyclic groups |
| 08/11/2004 | CN1520324A Antiangiogenic combination thereapy for treatment of cancer |
| 08/11/2004 | CN1520314A Drugs contg. chymase inhibitor and ace inhibitors as active ingredients |
| 08/11/2004 | CN1520310A Use of angiotensin derivative as agent for treatment and prevention of infarction-related cardiac injuries and disorders |
| 08/11/2004 | CN1520307A Combination of Chinese traditional medicine for treating angina pectoris as well as preparation method and usage |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520290A Carbocyclic hydrorazino inhibitors of copper-containing amine oxidases |
| 08/11/2004 | CN1520286A Gastric retention controlled drug delivery system |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1519325A Shuttle plasmid of adenovirus and its constructing method |
| 08/11/2004 | CN1519246A Salt of organic acid of cyclorrirobuxin-D, pharmaceutics and application as well as its preparation method |
| 08/11/2004 | CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase |
| 08/11/2004 | CN1519032A Plasmid for gene therapy of cardiac muscle |
| 08/11/2004 | CN1519025A Microzyme beverage modified in plasma environment for lowering high blood pressure |
| 08/11/2004 | CN1519015A Medication for treating hemorrhoids and preparation method |
| 08/11/2004 | CN1519013A Formulation of medication for treating homorrhoids |
| 08/11/2004 | CN1518999A Method for preparing pharmaceutics of a single drug of japanese ginseng and general saponin |
| 08/11/2004 | CN1518982A Active component of muskrat fragrant, preparing technique and usage |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161360C Tetrazole-containg rapamycin analogs with shortened half-lives |
| 08/11/2004 | CN1161356C Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha' |
| 08/11/2004 | CN1161352C Quinazoline derivatives |
| 08/11/2004 | CN1161341C Fused pydiopyridazine inhibitors of cGMP phosphodiesterase |
| 08/11/2004 | CN1161340C Benzimidazole compounds that are vitronectin receptor antagoninsts |
| 08/11/2004 | CN1161338C Fluorinated 3,4-dihydroquinoline derivatives used and NOS inhibitors |
| 08/11/2004 | CN1161314C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxyl] ethanol and pharmaceutical compositions thereof |
| 08/11/2004 | CN1161146C Chinese medicine for treating coronary heart disease, reducing blood fat and improving sleep and its preparing process |
| 08/11/2004 | CN1161140C Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 08/11/2004 | CN1161130C Composition for burn and scald |
| 08/11/2004 | CN1161128C Anigiogenic inhibitory compounds |
| 08/11/2004 | CN1161121C Alkaloid of matrine category utilized for mainline and its preparation method |
| 08/11/2004 | CN1161110C Oral delayed immediate release formulation and method of preparation therefor |
| 08/10/2004 | US6774259 Condensation of alanine with alkyl butyrate; hydrogenation using palladium-on-carbon catalyst in water and sodium hydroxide; precipitation, filtration; recrystallization from acetonitrile; purification |
| 08/10/2004 | US6774136 Substituted 1 and 2 naphthol mannich bases |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774112 Antidiabetic agents; cardiovascular disorders |
| 08/10/2004 | US6773724 Improved solubility |
| 08/10/2004 | US6773716 Over-coated chewing gum formulations |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region |
| 08/10/2004 | CA2306008C Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 08/10/2004 | CA2234899C Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist, method for preparation and use thereof in the treatment of cardiovascularillnesses |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065589A1 Method of preparing cell for transplantation |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065372A1 Tetrazole-functionalized amino acids, their production and use |
| 08/05/2004 | WO2004065369A1 Carboxamide derivatives and their use as factor xa inhibitors |
| 08/05/2004 | WO2004065365A1 8-azaprostaglandin derivatives and medicinal uses thereof |
| 08/05/2004 | WO2004065345A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity |
| 08/05/2004 | WO2004064912A1 An otorhinological delivery device |
| 08/05/2004 | WO2004064862A1 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 08/05/2004 | WO2004064858A1 Drug containing human arterial natriuretic peptide |
| 08/05/2004 | WO2004064842A1 Amide and ester matrix metalloproteinase inhibitors |
| 08/05/2004 | WO2004064836A2 Treatment of diseases with alpha-7 nach receptor full agonists |
| 08/05/2004 | WO2004064831A1 Compounds having anti-proliferative properties |
| 08/05/2004 | WO2004064830A1 Processed fat compositions for preventing and improving lifestyle-related diseases |
| 08/05/2004 | WO2004064823A1 Ceramide derivatives for the treatment of inflammation |
| 08/05/2004 | WO2004064820A2 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 08/05/2004 | WO2004064818A1 Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto |
| 08/05/2004 | WO2004064543A1 Compositions containing coenzyme q10 |
| 08/05/2004 | WO2004064542A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | WO2004043925A3 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 08/05/2004 | WO2004039453A3 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003086288A3 Bicyclic amides |
| 08/05/2004 | WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | WO2002043568A3 Identification of compounds that potentiate the activity of muscarinic potassium channels |
| 08/05/2004 | US20040153126 Method and apparatus for treating uterine myoma |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152786 Preventive or remedy for diseases caused by cerebrovascular disturbances |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152763 Cardiovascular disorders |
| 08/05/2004 | US20040152762 Oxidation resistance; from hesperidin using Aspergillus fermentation |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152757 Carvedilol |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 08/05/2004 | US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders |